AKT1 and chronic kidney disease: The results show that Shenkang injection has a good therapeutic effect on chronic renal failure, which may be achieved by pharmacodynamic substances such as HSYA, tanshinol, rheum emodin, Astragaloside IV, and the regulation of PI3K-Akt signaling pathway.